HRP20140676T1 - Formulacije deoksikolne kiseline i njezinih soli - Google Patents

Formulacije deoksikolne kiseline i njezinih soli Download PDF

Info

Publication number
HRP20140676T1
HRP20140676T1 HRP20140676AT HRP20140676T HRP20140676T1 HR P20140676 T1 HRP20140676 T1 HR P20140676T1 HR P20140676A T HRP20140676A T HR P20140676AT HR P20140676 T HRP20140676 T HR P20140676T HR P20140676 T1 HRP20140676 T1 HR P20140676T1
Authority
HR
Croatia
Prior art keywords
preparation
preparation according
vol
deoxycholic acid
salt
Prior art date
Application number
HRP20140676AT
Other languages
English (en)
Inventor
Robert Emil Hodge
Jeffrey Douglas Webster
Robert M. Moriarty
Original Assignee
Kythera Biopharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kythera Biopharmaceuticals, Inc. filed Critical Kythera Biopharmaceuticals, Inc.
Publication of HRP20140676T1 publication Critical patent/HRP20140676T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Claims (14)

1. Taložno stabilan vodeni farmaceutski pripravak, naznačen time što se uglavnom sastoji od 0,4% tež./vol. Do 1% tež./vol. soli deoksikolne kiseline i farmaceutski prihvatljive pomoćne tvari, te što se pH navedenog pripravka održava na 8,2 do 8,5.
2. Pripravak u skladu s patentnim zahtjevom 1, naznačen time što je navedena sol deoksikolne kiseline prisutna u količini od 0,5% tež./vol. do 1% tež./vol.
3. Pripravak u skladu s patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što je navedena sol deoksikolne kiseline prisutna u količini od 0,5% tež./vol.
4. Pripravak u skladu s patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što je navedena sol deoksikolne kiseline prisutna u količini od 1% tež./vol.
5. Pripravak u skladu s bilo kojim od patentnih zahtjeva 1 do 4, naznačen time što je navedena pomoćna tvar otapalo, pufer, konzervans, pomoćno sredstvo za liofiliziranje, ili bilo koja kombinacija navedenog.
6. Pripravak u skladu s patentnim zahtjevom 5, naznačen time što je navedena pomoćna tvar otapalo, poput sterile water.
7. Pripravak u skladu s patentnim zahtjevom 5, naznačen time što je navedena pomoćna tvar konzervans, poput benzil-alkohola.
8. Pripravak u skladu s patentnim zahtjevom 7, naznačen time što je navedeni konzervans 0,9%-tni benzilalkohol.
9. Pripravak u skladu s patentnim zahtjevom 1, naznačen time što navedeni pripravak ima pH od 8,3.
10. Pripravak u skladu s bilo kojim od patentnih zahtjeva 1 do 9, naznačen time što je navedeni pripravak injekcijski pripravak.
11. Pripravak u skladu s patentnim zahtjevom 10, naznačen time što je navedeni pripravak pripravak za supkutanu injekciju.
12. Pripravak u skladu s bilo kojim od patentnih zahtjeva 1 do 11, naznačen time što je navedena sol sol s alkalnim metalom.
13. Pripravak u skladu s patentnim zahtjevom 12, naznačen time što je navedena sol s alkalnim metalom natrijeva sol.
14. Pripravak u skladu s bilo kojim od patentnih zahtjeva 1 do 13, naznačen time što se deoksikolnu kiselinu sintetizira prema sljedećoj shemi: [image]
HRP20140676AT 2011-08-23 2014-07-15 Formulacije deoksikolne kiseline i njezinih soli HRP20140676T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11178538.2A EP2561876B1 (en) 2011-08-23 2011-08-23 Formulations of Deoxycholic Acid and Salts Thereof

Publications (1)

Publication Number Publication Date
HRP20140676T1 true HRP20140676T1 (hr) 2014-10-10

Family

ID=44651163

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20140676AT HRP20140676T1 (hr) 2011-08-23 2014-07-15 Formulacije deoksikolne kiseline i njezinih soli

Country Status (11)

Country Link
EP (4) EP2735310B1 (hr)
CY (1) CY1115372T1 (hr)
DK (2) DK3305298T3 (hr)
ES (3) ES2478447T3 (hr)
HR (1) HRP20140676T1 (hr)
HU (1) HUE046047T2 (hr)
PL (2) PL3305298T3 (hr)
PT (2) PT3305298T (hr)
RS (1) RS53419B (hr)
SI (1) SI2561876T1 (hr)
SM (1) SMT201400094B (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2675460A4 (en) 2011-02-18 2014-07-09 Kythera Biopharmaceuticals Inc TREATMENT OF FAT TISSUE UNDER CHIN
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
CN108366975A (zh) * 2015-11-04 2018-08-03 凯瑟拉生物制药有限公司 使用脱氧胆酸和其盐对堆积的脂肪的治疗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6417179B1 (en) * 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2660172T3 (es) 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Composición inyectable que comprende desoxicolato de sodio
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20090317376A1 (en) 2005-06-06 2009-12-24 Georgetown University Medical School Compositions And Methods For Lipo Modeling
TW201011755A (en) 2008-09-10 2010-03-16 Skymedi Corp Flash memory system and its data recovery method

Also Published As

Publication number Publication date
ES2478447T3 (es) 2014-07-22
EP2561876A1 (en) 2013-02-27
PT3305298T (pt) 2019-07-29
HUE046047T2 (hu) 2020-01-28
PL3305298T3 (pl) 2020-02-28
PL2561876T3 (pl) 2014-09-30
DK3305298T3 (da) 2019-07-29
SMT201400094B (it) 2014-11-10
EP3305298B1 (en) 2019-05-01
ES2738500T3 (es) 2020-01-23
ES2655465T3 (es) 2018-02-20
EP2735310B1 (en) 2017-10-11
CY1115372T1 (el) 2017-01-04
PT2561876E (pt) 2014-07-18
RS53419B (en) 2014-12-31
EP2735310A1 (en) 2014-05-28
EP3305298A1 (en) 2018-04-11
EP3511007A1 (en) 2019-07-17
DK2561876T3 (da) 2014-07-21
EP2561876B1 (en) 2014-04-16
SI2561876T1 (sl) 2014-08-29

Similar Documents

Publication Publication Date Title
HRP20171270T1 (hr) Liofilizirani spoj
HRP20140676T1 (hr) Formulacije deoksikolne kiseline i njezinih soli
HRP20200434T1 (hr) Stabilne vodene formulacije adalimumaba
HRP20200998T1 (hr) Postupak i sastav za liječenje okularne hipertenzije i glaukoma
HRP20210179T1 (hr) Farmaceutski pripravak za modificirano otpuštanje
AR113034A2 (es) Formulación líquida de un conjugado de la hormona del crecimiento humano de efecto prolongado
HRP20171512T1 (hr) Derivati betulina
HRP20210743T1 (hr) Hemisulfatna sol 5,10-metilen-(6r)-tetrahidrofolne kiseline
HRP20221294T1 (hr) Neuroaktivni steroidi, njihovi pripravci i uporabe
BR112012018384A2 (pt) composição farmacêutica sólida com intensificadores e métodos de preparação da mesma.
MD20150050A2 (ro) Soluţii midriatice şi antiinflamatorii stabile fără conservanţi pentru injectare
RU2015132431A (ru) Составы, содержащие антитела
PE20080423A1 (es) Formulaciones de flibanserina y metodo para fabricarlas
AR095396A1 (es) Formulaciones de anticuerpo
JP2018532806A5 (hr)
NZ592647A (en) Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
EA201600118A1 (ru) Жидкая водная фармацевтическая композиция с консервантами, содержащая этерифицированные производные циклодекстрина
RU2012155711A (ru) Жидкий назальный спрей, содержащий налтрексон в низкой дозе
AR082049A1 (es) Formulaciones liquidas de rupatadina fumarato
HRP20180479T1 (hr) Veterinarski postupak za ublažavanje averzije prema buci
MY184277A (en) Formulations of deoxyccholic acid and salts thereof
JP2019535766A5 (hr)
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
HRP20150578T1 (hr) Metoda za stabilizaciju s-nitrozoglutationa i sastav pripremljen tom metodom
SI2961481T1 (en) Topical antimicrobial dermatological composition